Qube Research & Technologies LTD Omeros Corp Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.48 - $5.22 $27,684 - $58,270	-11,163 Reduced 19.66%	45,604 $212,000
Q4 2022 Feb 14, 2023	BUY	$1.75 - $3.96 $18,994 - $42,981	10,854 Added 23.64%	56,767 $128,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $7.46 $15,196 - $36,688	4,918 Added 12.0%	45,913 $145,000
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $78,710 - $257,448	40,995 New	40,995 $113,000
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $280,850 - $341,631	-20,959 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$14.81 - $19.13 $90,740 - $117,209	6,127 Added 41.31%	20,959 $311,000
Q1 2021 May 14, 2021	BUY	$14.52 - $23.53 $215,360 - $348,996	14,832 New	14,832 $264,000
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $156,267 - $234,093	-15,411 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$9.57 - $21.32 $147,483 - $328,562	15,411 New	15,411 $156,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.